Covid-19 has brought much of the world to a halt this year. However, it is just one of the many infectious diseases without a vaccine that affect millions of people around the world. The development of therapeutics for these infectious diseases has mostly been overlooked by pharmaceutical companies in favor of higher-margin therapies for the developed world. Creating therapeutics for these viral pathogens can take years of clinical and regulatory assessment before they become available to those who need them. Ram Sasisekharan, the Alfred H. Caspary Professor of Biological Engineering,…
